Search research articles
Contact Us
Filters
Showing results (281-290 of 789) with videos related to
Page
of 79
Sort By:
Psychopharmacology
|
May 10, 2021
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21
C Sakal, M Lynskey, A K Schlag, et al.
Psychopharmacology
|
January 1, 1991
Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil
D M Ball, P Glue, S Wilson, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 4, 2008
The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures
A Papadopoulos, A Rich, D J Nutt, et al.
Neuropharmacology
|
March 1, 1996
TNF alpha mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain
S Tolchard, A S Hare, D J Nutt, et al.
Neuropharmacology
|
September 1, 1980
Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures
D J Nutt, A R Green, D G Grahame-Smith
Journal of Psychopharmacology (Oxford, England)
|
June 20, 2008
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety
J E Bailey, A Papadopoulos, K Seddon, et al.
Psychopharmacology
|
December 17, 2008
Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al
Sean D Hood, Simon J C Davies, David J Nutt
Acta Psychiatrica Scandinavica
|
December 1, 1991
The criteria of Cloninger et al. and von Knorring et al. for subgrouping alcoholics: a comparison in a clinical population
D M Lamparski, A Roy, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man
J E Bailey, J Potokar, N Coupland, et al.
Annals of Neurology
|
April 1, 1986
Monozygotic twins with Parkinson's disease
W Koller, R O'Hara, J Nutt, et al.
Page
of 79
Search research articles
Search
Showing results (281-290 of 789) with videos related to
Sort By:
Page
of 79
Psychopharmacology
|
May 10, 2021
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21
C Sakal, M Lynskey, A K Schlag, et al.
Psychopharmacology
|
January 1, 1991
Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil
D M Ball, P Glue, S Wilson, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 4, 2008
The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures
A Papadopoulos, A Rich, D J Nutt, et al.
Neuropharmacology
|
March 1, 1996
TNF alpha mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain
S Tolchard, A S Hare, D J Nutt, et al.
Neuropharmacology
|
September 1, 1980
Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures
D J Nutt, A R Green, D G Grahame-Smith
Journal of Psychopharmacology (Oxford, England)
|
June 20, 2008
A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety
J E Bailey, A Papadopoulos, K Seddon, et al.
Psychopharmacology
|
December 17, 2008
Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al
Sean D Hood, Simon J C Davies, David J Nutt
Acta Psychiatrica Scandinavica
|
December 1, 1991
The criteria of Cloninger et al. and von Knorring et al. for subgrouping alcoholics: a comparison in a clinical population
D M Lamparski, A Roy, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man
J E Bailey, J Potokar, N Coupland, et al.
Annals of Neurology
|
April 1, 1986
Monozygotic twins with Parkinson's disease
W Koller, R O'Hara, J Nutt, et al.
Page
of 79